Beta Bionics Announces iLet Bionic Pancreas is Now Added to the Express Scripts National Commercial Formularies
CONCORD, Mass., November 14, 2023: Beta Bionics, Inc., a pioneering leader in the development of advanced diabetes management solutions, announced that effective November 10th, Express Scripts has added the iLet Bionic Pancreas and associated monthly supplies to their commercial national formulary offerings. For plans that cover the iLet Bionic Pancreas under their pharmacy benefit and […]